SJ Khan, E Kapoor, SS Faubion… - International Journal of …, 2023 - Taylor & Francis
Vasomotor symptoms affect as many as 80% of midlife women, but only about one in four women receive treatment due to many factors. Menopausal hormone therapy remains the …
C Martinez, S Suissa, S Rietbrock, A Katholing… - bmj, 2016 - bmj.com
Objective To determine the risk of venous thromboembolism associated with use of testosterone treatment in men, focusing particularly on the timing of the risk. Design …
C Hotoleanu - Medicine and pharmacy reports, 2020 - ncbi.nlm.nih.gov
Methods A case-control study including 732 patients was designed. Collected data included: age, gender, body mass index, pregnancy/postpartum state, use of hormonal therapy …
E Kapoor, JM Kling, AS Lobo, SS Faubion - Best Practice & Research …, 2021 - Elsevier
Hormone therapy is the most effective treatment for menopause-related symptoms. Current evidence supports its use in young healthy postmenopausal women under the age of 60 …
FJ Cameron, R Amin, C De Beaufort, E Codner… - Pediatric …, 2014 - orbilu.uni.lu
[en] The article presents a part of the guidelines on pediatric diabetes in the International Society for Pediatric and Adolescent Diabetes (ISPAD) Clinical Practice Consensus …
BO Yildiz - The Journal of Clinical Endocrinology & Metabolism, 2015 - academic.oup.com
Polycystic ovary syndrome (PCOS) is a common reproductive and metabolic disorder. Patients with PCOS present with clinical signs of androgen excess (ie, hirsutism and acne) …
DB Kell, E Pretorius - Progress in biophysics and molecular biology, 2017 - Elsevier
The chief and largely terminal element of normal blood clotting is considered to involve the polymerisation of the mainly α-helical fibrinogen to fibrin, with a binding mechanism …
M Stewart, K Black - Australian prescriber, 2015 - ncbi.nlm.nih.gov
The combined oral contraceptive pill is an effective contraceptive method which can also offer other benefits. However, other contraceptive options should be discussed. If the pill is …
AH Bryk, M Piróg, K Plens, A Undas - Vascular pharmacology, 2016 - Elsevier
Anticoagulants increase the risk of heavy menstrual bleeding (HMB). We sought to investigate the incidence, predictors and management of HMB in women on rivaroxaban …